Rachael Lester insider trades

Open-market stock purchases and sales by Rachael Lester, Chief Business Officer at CytomX Therapeutics, Inc, from SEC Form 4 filings since Oct 20, 2025.

Recent trades

DateStockTradeValue
Feb 2, 2026CTMX CytomX Therapeutics, IncBought (not open market)—
Feb 2, 2026CTMX CytomX Therapeutics, IncBought (not open market)—
Oct 20, 2025CTMX CytomX Therapeutics, IncBought (not open market)—

Companies traded

  • CTMX CytomX Therapeutics, Inc: other filings, last Feb 2, 2026

Get free alerts when Rachael Lester files a new trade →